Instituto Portugues de Oncologia, Francisco Gentil, Porto
12
3
3
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Assessment of the Role of Incisura Biopsy in the Staging of Chronic Gastritis
Role: collaborator
Reengineering Cervical Cancer Screening for the 21st Century: Joint Action for a Novel Up-to-date and Sustainable Screening Program
Role: collaborator
Implementation, Effectiveness and Impact of a Value Based Intervention for Patients with Breast or Lung Cancer
Role: collaborator
HPV Self-sampling for Women Who do Not Attend Cervical Cancer Screening Programme
Role: collaborator
BLI for the Diagnosis of Precancerous Conditions
Role: lead
The Modulatory Role of Internet MBCT on Extracellular Vesicles and Distress in Cancer Patients - Study Protocol
Role: lead
Comparison on Radiotherapy Permanent Skin Marking With Lancets and an Electric Marking Device
Role: lead
SUrveillance of PREMalignant Stomach - Individualized Endoscopic Follow-up
Role: lead
Neoadjuvant Immunotherapy With Durvalumab (MEDI4736) in Non-Surgical Early Stage or Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Followed by Radical Radiotherapy or Chemoradiotherapy
Role: lead
Impact of Group Psychological Interventions on Extracellular Vesicles in People Who Had Cancer
Role: lead
Effectiveness of a Structured Intervention on the Development of Self-Care Behaviors With AVF in HD Patients
Role: lead
Efficacy of US-guided TAP Block in Breast Reconstruction Surgery With Abdominal Myocutaneous Flap
Role: lead
All 12 trials loaded